EU Agency backs new drugs from GSK, Novartis, J&J
February 21, 2014 at 07:37 AM EST
LONDON, Feb 21 (Reuters) - European regulators said on Friday they had recommended approval of 10 drugs, six of which were for respiratory diseases including GlaxoSmithKline's Anoro and Laventair and Novartis's Ulunar Breezhaler.
